Three new NHMRC Centres for Research Excellence (CREs) dedicated to type 1 diabetes have received combined funding of $7.5m through the National Health and Medical Research Council (NHMRC) and JDRF.
The CREs will conduct research into new ways to prevent, treat and manage complications of type 1 diabetes, and investigate how to improve the translation of new technologies for managing diabetes into clinical practice.
NHMRC CEO Professor Warwick Anderson said, “NHMRC has had a productive, longstanding relationship with JDRF. The jointly funded CREs announced today are the latest in a long line of collaborations between our two organisations.”
“Through our relationship, we have supported some of Australia’s finest researchers in their investigations to find new ways to improve the lives of people with diabetes and to bring us closer to preventing this condition in future,” he said.
“NHMRC’s CREs are uniquely designed to promote and improve the translation of research outcomes into policy and practice and I am confident that these three CREs will contribute much to our understanding of how to better tackle type 1 diabetes.”
The three CREs funded are:
|Prof Mark Cooper
||Baker IDI Heart and Diabetes Institute
||To translate new experimental findings into strategies for the prevention, treatment and management of type 1 diabetes and its complications, as well as training clinical investigators in this field.
|Prof Jennifer Couper
||University of Adelaide
||To study genetic and environmental influences as factors that impact early immune function, to better identify modifiable risk factors and improved methods of predicting and preventing type 1 diabetes.
|Prof Timothy Jones
||University of Western Australia
||To study the economic, psychological and behavioural factors that keep diabetes technologies from reaching their full useability potential, and promote the translation of these technologies into clinical practice.
JDRF Australia CEO Mike Wilson said, “JDRF is proud to be partnering again with the NHMRC. We know that the funding announced today will enable significant progress to be made by the three outstanding recipients.”
The grants were part of a $539.8 million announcement made last week by the Australian Government for 773 grants across a broad range of diseases and health conditions.